The Association Between NLRP3 and The Development of Depression in Type 2 Diabetes Patients
DOI:
https://doi.org/10.46966/msjar.v5i2.177Keywords:
Insulin Resistance, Inflammatory Cytokines, Chronic Disease, Depression, InflammasomeAbstract
Background: Type 2 diabetes is a chronic disease characterized by two characteristics: insulin resistance and destruction of pancreatic beta cells, leading to high blood sugar levels. This disease is associated with many complications that can be serious and life-threatening, such as depression. The presence of inflammatory components like inflammatory cytokines and immune protein complexes in high concentrations in the blood of type 2 diabetes patients has led to theories and studies that support the involvement of certain inflammatory pathways in the relationship between these two diseases. Method: This cross-sectional study included the selection of 128 individuals diagnosed with type 2 diabetes from the Diabetes and Endocrinology Center located in Najaf, Iraq from August 2023 to October 2023. The study included 43 men and 85 women. The ages of the participants ranged from 30 to 75 years. Patients were randomly selected during their visit to the center.Depression was diagnosed using the Hamilton scale, a blood serum sample was taken, and the NLRP3 level was measured using the ELISA device. Result: The results ultimately showed that inflammasome levels were higher in people with depression than in patients with type 2 diabetes than in patients with diabetes who did not have depression, and the difference was statistically significant p-value (0.020).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Zahraa Mohammed Hussein AL. Khaqani1 And, Thanaa Shams Al-Deen Al-Turaihi2
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
